Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cue Biopharma (CUE) Current Deferred Revenue (2017 - 2018)

Cue Biopharma (CUE) has disclosed Current Deferred Revenue for 2 consecutive years, with $381465.0 as the latest value for Q4 2018.

  • Quarterly Current Deferred Revenue rose 949.02% to $381465.0 in Q4 2018 from the year-ago period, while the trailing twelve-month figure was $381465.0 through Dec 2018, up 949.02% year-over-year, with the annual reading at $381465.0 for FY2018, 949.02% up from the prior year.
  • Current Deferred Revenue hit $381465.0 in Q4 2018 for Cue Biopharma, up from $225000.0 in the prior quarter.
  • In the past five years, Current Deferred Revenue ranged from a high of $381465.0 in Q4 2018 to a low of $36364.0 in Q4 2017.